These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24172809)

  • 1. Long-term prostaglandin E1 use in newborns with duct-dependent congenital heart diseases: one year experience of a tertiary neonatal intensive care unit in Turkey.
    Ustün N; Dilli D; Zenciroğlu A; Okumuş N; Cınar G; Ozgür S; Koç M
    Anadolu Kardiyol Derg; 2013 Nov; 13(7):732-4. PubMed ID: 24172809
    [No Abstract]   [Full Text] [Related]  

  • 2. Morphologic features of the ductus arteriosus after prostaglandin E1 administration for ductus-dependent congenital heart defects.
    Park IS; Nihill MR; Titus JL
    J Am Coll Cardiol; 1983 Feb; 1(2 Pt 1):471-5. PubMed ID: 6681824
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anesthesia for neonates and young infants with ductus dependent cardiac malformations treated with prostaglandin E1].
    Fujii S; Nagai I; Yonei A; Sari A; Baba K
    Masui; 1984 May; 33(5):545-9. PubMed ID: 6540818
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of preoperative administration of prostaglandin E1 on cerebral blood flow in newborns with ductal-dependent congenital cardiac malformations].
    Simon M; Cucerea M; Dimitriu AG; Stamatin M
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(2):399-407. PubMed ID: 20700975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nursing care of the neonate receiving prostaglandin E1 therapy.
    Rikard DH
    Neonatal Netw; 1993 Jun; 12(4):17-22. PubMed ID: 8510622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical hyperostosis simulating osteomyelitis after short-term prostaglandin E1 infusion.
    Kalloghlian AK; Frayha HH; deMoor MM
    Eur J Pediatr; 1996 Mar; 155(3):173-4. PubMed ID: 8929722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reappraisal of the prostaglandin E1 dose for early newborns with patent ductus arteriosus-dependent pulmonary circulation.
    Huang FK; Lin CC; Huang TC; Weng KP; Liu PY; Chen YY; Wang HP; Ger LP; Hsieh KS
    Pediatr Neonatol; 2013 Apr; 54(2):102-6. PubMed ID: 23590954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E1 treatment in patent ductus arteriosus dependent congenital heart defects.
    Tálosi G; Katona M; Rácz K; Kertész E; Onozó B; Túri S
    J Perinat Med; 2004; 32(4):368-74. PubMed ID: 15346826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E1 in infants with congenital heart disease: Indian experience.
    Saxena A; Sharma M; Kothari SS; Juneja R; Reddy SC; Sharma R; Bhan A; Venugopal P
    Indian Pediatr; 1998 Nov; 35(11):1063-9. PubMed ID: 10216540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prostaglandin E1 in newborn infants with ductus-dependent heart diseases. Review of 40 cases].
    Simões LC; Sarachaga IH; Quero M; Casanova M; Cazzaniga M; Villibre D
    Arq Bras Cardiol; 1985 Jul; 45(1):31-6. PubMed ID: 3938651
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prostaglandin treatment of ductus-dependent congenital heart defects].
    Olsson B; Björkhem G; Lundström NR
    Lakartidningen; 1984 Oct; 81(40):3619-22. PubMed ID: 6541738
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of oral and intravenous Ibuprofen for medical closure of patent ductus arteriosus: which one is better?
    Olukman O; Calkavur S; Ercan G; Atlihan F; Oner T; Tavli V; Kultursay N
    Congenit Heart Dis; 2012; 7(6):534-43. PubMed ID: 22613269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of prostaglandins in duct-dependent congenital heart conditions.
    Singh Y; Mikrou P
    Arch Dis Child Educ Pract Ed; 2018 Jun; 103(3):137-140. PubMed ID: 29162633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E1 treatment of congenital heart disease: use prior to neonatal transport.
    Buck ML
    DICP; 1991 Apr; 25(4):408-9. PubMed ID: 1926911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered prostaglandin E1 dosage during extracorporeal membrane oxygenation in a newborn with ductal-dependent congenital heart disease.
    Stone DM; Frattarelli DA; Karthikeyan S; Johnson YR; Chintala K
    Pediatr Cardiol; 2006; 27(3):360-3. PubMed ID: 16565906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of prostaglandins in neonatal cardiology].
    Dinarević S; Kurtagić S; Maksić H
    Med Arh; 2000; 54(5-6):279-82. PubMed ID: 11219904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified Blalock-Taussig shunt following long-term administration of prostaglandin E1 for ductus-dependent neonates with cyanotic congenital heart disease.
    Yokota M; Muraoka R; Aoshima M; Nomoto S; Shiraishi Y; Kyoku I; Kitano M; Shimada I; Nakano H; Ueda K
    J Thorac Cardiovasc Surg; 1985 Sep; 90(3):399-403. PubMed ID: 4033176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of prostaglandin E1 infusion in the pre-operative management of critical congenital heart disease.
    Ohara T; Ogata H; Fujiyama J; Murata Y; Abe J; Kakuta K; Hayamizu S; Kameyama S; Yoshida Y
    Tohoku J Exp Med; 1985 Jun; 146(2):237-49. PubMed ID: 4040664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of very low-dose prostaglandin E1 in duct-dependent congenital heart disease.
    Yucel IK; Cevik A; Bulut MO; Dedeoğlu R; Demir İH; Erdem A; Celebi A
    Cardiol Young; 2015 Jan; 25(1):56-62. PubMed ID: 24168719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of ductus-dependent congenital heart diseases with prostaglandin E1].
    Lillquist K
    Ugeskr Laeger; 1979 Jul; 141(28):1915-6. PubMed ID: 473414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.